Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Contentious grain bill put directly to plenary meeting for vote

    Contentious grain bill put directly to plenary meeting for vote
  2. 2

    Yoon's approval rating plunges to all-time low

    Yoon's approval rating plunges to all-time low
  3. 3

    Will tug-of-war between doctors, government end soon?

    Will tug-of-war between doctors, government end soon?
  4. 4

    Climate impacts set to cut 2050 global GDP by nearly a fifth

    Climate impacts set to cut 2050 global GDP by nearly a fifth
  5. 5

    Trilateral talks acknowledge ‘serious’ slumps of won, yen

    Trilateral talks acknowledge ‘serious’ slumps of won, yen
  1. 6

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
  2. 7

    North Korea removes streetlights along cross-border roads with South

    North Korea removes streetlights along cross-border roads with South
  3. 8

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
  4. 9

    Farming households dip below 1m for first time in 2023

    Farming households dip below 1m for first time in 2023
  5. 10

    S. Korea votes in favor of Palestinian bid for UN membership

    S. Korea votes in favor of Palestinian bid for UN membership
소아쌤

Boryung to invest W24b in innovative US health care firms through Hayan I, L.P.

By Lim Jeong-yeo

Published : July 1, 2020 - 16:28

    • Link copied

Boryung Pharmaceutical said Wednesday it will make an incremental 24 billion won ($20 million) investment in innovative US health care firms.

The investment will be carried out over three years by Hayan I, L.P., which is a corporate venture capital fund established in the US by Boryung.

Boryung Pharmaceutical plans to strengthen its pipelines for novel drugs development through open innovation with the promising companies it invests in in the US.

Boryung’s US entity, Hayan Health Networks, was established in January by Boryung Holdings. It is headed by Choi Sung-won, also known as Peter Choi, who doubles as the head of Global Business Department at Boryung Pharmaceutical.

Choi has a bachelor of science degree in microbiology from the University of Michigan, and another bachelor of science degree in biochemistry from the University of Washington. He also has a master of science degree in pathology from the University of Washington.

Choi has 20 years of experience in pharmaceutical business development.

By Lim Jeong-yeo (kaylalim@heraldcorp.com)

More from Headlines